Fig. 3.
Effects of (A) MOC (mg/mL), (B) MN (μM), HK (μM) and MK 571 (50 μM, a specific inhibitor of MRP2) on the intracellular accumulation of GSMF (mean ± S.D.) in MDCKII-WT cells. (C) Effects of MOCM (1- and 1/2-fold serum concentration) and MK 571 (100 μM, spiked in blank serum) on the intracellular accumulation of GSMF (mean ± S.D.) in MDCKII-MRP2 cells. (*P < 0.05, **P < 0.01, ***P < 0.001).